Digital Screens and DED: Unveiling the Link

Dear Dr. Renukaprasad A R, How does long-term digital screen usage affect meibomian gland structure and function? Working with visual display terminals (VDTs) is becoming increasingly important in the global information age. Long-term VDTs usage, especially for more than four hours daily, is associated with a high incidence of dry eye disease (DED). Recent clinical studies have suggested that meibomian gland dysfunction (MGD), caused by long-term VDTs work, plays a more significant role in determining the severity of dry eye. Watch this exciting video to know more about DED and computer vision syndrome (CVS) and the association between digital screen use and DED. Highlights - Definition, etiology, and clinical manifestations of DED CVS and its impact on the eye MGD and goblet cell dysfunction in digital screen users Prevention and treatment approaches for CVS Click to Watch Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Autoantibodies: Detecting T1DM with Precision

Dear Dr. Renukaprasad A R, Are you familiar with the autoimmune markers in type 1 diabetes mellitus (T1DM) testing? The prevalence of type 1 diabetes (T1DM) is on a steady rise globally and India stands to be the second leading country with 818,620 cases. Key autoimmune markers, including glutamic acid decarboxylase autoantibodies (GADA), islet cell autoantibodies (ICA), protein tyrosine phosphatase autoantibodies (IA-2A), insulin autoantibodies (IAA), and zinc transporter 8 autoantibodies (ZnT8A), play a critical role in both the diagnosis and prognosis of this condition. A specific, standardized test panel can help detect all these antibodies. Check out this infographic about the role of autoantibodies in T1DM and a specialized test panel exclusively designed for their diagnosis. Highlights: T1DM prevalence in India Role of autoantibodies in T1DM The tests offered by Metropolis for autoantibody detection Click to Know More Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Access Opening in Root Canal Treatment, Carcinoma Larynx, and More

Dear Renukaprasad A R, A brand-new week means a brand-new schedule of engaging sessions! Join our distinguished speakers as they share their insights on the recent developments in the field of medical sciences. Stay tuned for these exciting sessions! Save the Date Carcinoma Larynx Laryngeal cancers contribute to one-third of head and neck cancers. Early detection of these cancers helps cure them using surgical or radiation monotherapy, preserving the larynx. Learn more about laryngeal cancers in an exclusive session on 28th August 2023, 6:00 PM IST onwards. Unlocking the Secrets: Exploring Access Opening in Root Canal Treatment Access cavity preparation aims to identify the root canal entrances for subsequent preparation and obturation of the root canal system, which can be the most challenging part of the treatment. To learn more about the topic, join us in a Dent-E-ssentials session on 1st September 2023, 3:00 PM IST onwards. Save the Date Watch News India: Health Ministry Urged to not Remove Respiratory Medicine from MBBS, and More India: Health Ministry Urged to not Remove Respiratory Medicine from MBBS Malaysia Advises Parents to Immunize Their Children Against Pertussis Retinal Imaging Detects Parkinson's Disease Seven Years Before Diagnosis USA Faces Surge in Pediatric Mental Health Emergencies Docplexus Online Services Pvt. Ltd. A-302, Teerth Technospace, Mumbai-Bengaluru Highway, Baner, Pune-411045, India.   If you have any questions, feel free message us at support@mailus.com. All right reserved. Update email preferences or Unsubscribe.